Healthcare

Global Regenerative Medicine Market by Technology

December 30, 2019
ID: SR/HC-01
Format:Pdf
Pages:220

Global Regenerative Medicine Market by Technology (Cellular Therapy, Gene Therapy, Tissue Engineering, and Exosome Therapeutics), By Source (Autologous and Allogenic), By Application (Dermatology, Musculoskeletal, Oncology, Cardiovascular, Neurology, Hematology & Immunology, and Others), By End-Users(Hospitals, Ambulatory surgery centers (ASCs), Clinics and Others), and By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)

Description

Global Regenerative Medicine Market Overview

Regenerative medicine refers to the use of biological and engineering theoretical methods to create lost or functionally damaged tissues and organs. Regenerative medicine can be described as the theory, technology, and surgical operations of tissue regeneration in the body. It can also consider as a discipline that studies how to promote the physiological repair of trauma and tissue and organ defects and how to perform tissue and organ regeneration and functional reconstruction.

Regenerative medicine marks a new era for the medicine to rebuild, regenerate, manufacture, and replace tissues and organs. It also brings new hope for most medical problems facing humans, such as cardiovascular disease, autoimmune diseases, diabetes, Malignant tumors, Alzheimer’s disease, Parkinson’s disease, congenital genetic defects, and other diseases and the treatment of various tissue and organ damage.

Global Regenerative Medicine Market Insights

Global Regenerative Medicine Market expected to grow with a CAGR 19.14% during the estimated period, 2019-2027 and projected to generate revenue of USD 190.08 Billion by 2027. The rise in the prevalence of chronic diseases & trauma emergencies and the emergence of stem cell technology is likely to boom the global regenerative medicine market in the forecast period. Additionally, conditions related to aging has become a significant medical and social problem across the globe, which leads to the growth of the global regenerative medicine market. Moreover, the rise in the number of patients with cardiovascular disease, diabetes, and millions of patients with Alzheimer’s disease and hematological tumors will accelerate the global regenerative medicine market.

Furthermore, accelerating the development of the regenerative medicine market is of great and practical significance for improving human living standards and benefiting human health. Further, the surge in funding for regenerative medicine research, and increasing demand for regenerative medicine for the treatment of cancer, orthopedic disorders, and chronic wounds are vital factors projected to trigger the global regenerative medicine market.

Growth Driver

The rise in diseases related to aging and chronic diseases

The increase in diseases related to aging has become a significant medical and social problem. At present, one of the primary causes among the elderly population is cell aging, which leads to issues such as cell damage, the development of inflammatory processes, slow regeneration, and reduced functional activity of corresponding tissues and organs. According to WHO, the proportion of the burden of non-communicable diseases anticipated to increase to 57% by 2020. Almost half of the total chronic disease deaths are attributable to cardiovascular diseases, obesity, and diabetes. It has projected that, by 2020, chronic diseases will account for almost three-quarter of all deaths worldwide, and that 71% of deaths due to ischaemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries.

Rising Government Investments in Regenerative Medicine

Governments and people in various countries have actively invested considerable resources in recent years to develop regenerative medicine. In the Asia Pacific, Japan is the first country to propose specific legislation of the global regenerative medicine. Clinical trials would also begin in areas such as the retina, the esophagus, heart, etc. World Health Organization (WHO) launched an initiative to eliminate hepatitis by 2030.

Resolving past incurable diseases with the help of human tissue or organ regeneration

Regenerative medicine aimed at repairing, replacing, and rejuvenating tissues or organs to improve human life caused by trauma, disease, or natural aging. It combines different specialties across fields, including biology, chemistry, computer science, genetics, robotics, etc., not only to activate the body’s original natural repair mechanism, but also to make it doubly useful. According to the World Bank, the population aged 65 and above increased from 7.64% in 2010 to 8.92% of the overall population in 2018.

Technology Segmental Analysis

Based on technology, the global Regenerative Medicine Market categorized into Cellular Therapy, Gene Therapy, Tissue Engineering, and Exosome Therapeutics. The Cellular Therapy segment projected to lead the market and witnessed to exhibit 48.53% market share in 2018, owing to its efficiency in restoring the lost function of tissues and organs. Cellular Therapy can solve the problem of organ transplantation, and organ transplantation can become one of the means of cancer treatment. The gene therapy segment will drive by its application to reduce levels of the disease-causing version of a protein and increase the production of disease-fighting proteins.

Source Segmental Analysis

Based on the Source, the Global Regenerative Medicine Market bifurcated into Autologous and Allogenic. The Autologous segment estimated to exhibit 61.14% market share in 2018 and anticipated to dominate the market due to their features such as cells derived from patients themselves. The use of autologous is a safe therapeutic option as the cells will not elicit an immune response. Allogenic will grow by its properties, such as the stem cells are from a donor. Allogenic do not elicit robust immune responses.

Application Segmental Analysis

Based on the application, the Global Regenerative Medicine Market segmented into Dermatology, Musculoskeletal, Oncology, Cardiovascular, Neurology, Hematology & Immunology, and Others. The oncology segment witnessed to exhibit 43.47% market share in 2018 and expected to dominate the market due to the surge in the cancer-affected population along with huge investments done in research related to cancer and development of regenerative & advanced cell therapies by the various government in developing and developed countries.

The dermatology segment will driven by the presence of easy grafting techniques for dermatological wounds and diseases related to skin.

End-User Segmental Analysis

By the End-user, the Global Regenerative Medicine market segregated into Hospitals, Ambulatory surgery centers (ASCs), Clinics, and Others. The Hospital segment generated the highest revenue with 52.46% market share in 2018 and anticipated to dominate the market over the forecast period due to the partnership formed between hospitals and regenerative medicine manufacturing companies to provide cell therapy and tissue scaffolds to improve patient care and treatment. The clinics’ segment will grow on account of certified clinics that offer healthcare services to people. These centers have specialized departments for regenerative medicine, which provide care and treatment.

Region Segmental Analysis

Based on geography, the global Regenerative Medicine market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America attributed to generating 41.68% market share in 2018 and estimated to generate USD 66.57 Billion revenue by 2027 owing to the availability of advanced technologies and the presence of research institutes and the rising initiatives by government and private organizations. Europe will be the fastest-growing region with a CAGR of 19.33% during the forecast period. It has generated revenue of 64.32 USD Billion in 2017 on account of the enormous growing aging population along with rising medical needs of the people and changing lifestyle.

Competitor Analysis

Companies such as Integra LifeSciences Corporation, MiMedx Group, Inc., AstraZeneca, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Pfizer Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Medtronic Plc., Athersys Inc., US Stem Cell, Organogenesis Inc., Acelity Holdings Inc., Isto Biologics, Cryolife Inc. and Baxter are the key players in the Global Regenerative Medicine Market.

Key Stakeholders

Market research and consulting firms
Industry associations
Global Regenerative Medicine Service Providers
Research organizations and consulting companies
Organizations, associations, and alliances related to Regenerative Medicine
Regulatory bodies

Scope of the report

Report Attribute	Details
Market size value in 2020	USD 64.6 Billion
Revenue forecast in 2027	USD 190.08 Billion
Growth Rate	CAGR of 19.14% from 2020 to 2027
Historical data	2017-2019
Forecast period	2021 – 2027
Region covered	America, Europe, Asia-Pacific, South America, and Middle East & Africa
Key companies Profiled	Integra LifeSciences Corporation, Pfizer Inc., MiMedx Group, Inc., AstraZeneca, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Acelity Holdings Inc., Isto Biologics, Cryolife Inc., Medtronic Plc., Athersys Inc., US Stem Cell, Organogenesis Inc., and Baxter.

Recent Developments

In September 2021, a rare autologous bone marrow cell transplant was done for the first time at Raj Hospital, Ranchi, Jharkhand.
In September 2021, the first-ever Genome sequencing lab opened in Tamil Nadu to detect SARS-CoV-2 virus variants.
In September 2021, QC Kinetix launched a state-of-the-art regenerative medicine clinic in Fort Worth, Dallas, TX.

The objective of the Research

Market Modelling Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
Product Analysis Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
Market Trend and Economic Factors Analysis This analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
Market Segmental Analysis Segmental analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
Geographical Mapping The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.

Market Modelling

By Technology

Cellular Therapy
Gene Therapy
Tissue Engineering
Exosome Therapeutics

By Source

Autologous
Allogenic

By Application

By End-Users

Hospitals
Ambulatory surgery centers (ASCs)
Clinics
Others

By Region

North America
Europe
Asia Pacific
South America
Middle East & Africa

Table Of Contents

Methodology

Request Sample

Frequently Asked Questions (FAQ):

What does regenerative medicine mean?

Regenerative medicine refers to biological and theoretical engineering methods to create lost or functionally damaged tissues and organs.

How big is the regenerative medicine market?

The regenerative medicine market is projected to generate revenue of USD 190.08 Billion by 2027.

Cell therapies, tissue engineering and immunomodulation therapy, are examples of regenerative medicine.

What is the growth rate of the global regenerative medicine market?

What are the growth drivers of the global regenerative medicine market?

Rising Government investments, Resolving past incurable diseases by human tissue or organ regeneration and increasing illnesses related to aging and chronic diseases are the growth drivers of the global regenerative medicine market.

Select License

We Accept

Analyst support

After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.

Customer satisfaction

According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.

Inimitable expertise

Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.

Assured quality

We have created a systematic way to determine standards and satisfy your expectations.

Instant delivery

Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.

Privacy policy

We understand the inkling of your privacy, we will never misuse your email address.

Custom research service

We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.

Quality & accuracy

We provide you with the accurate quality of the customized study of an exclusive report according to your research need.

Data visualization

As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.

Information security

We truly respect your privacy and promise to keep your personal and confidential information safe and secure.